Intchains vs Nano Labs
ICG and NA side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ICG and NA compare
Intchains grew revenue faster over the last twelve months (−21.6% versus −33.5% for Nano Labs).
Nano Labs keeps more of each dollar of sales as profit, with a net margin of 502% compared with −21.5% at Intchains.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ICG | NA |
|---|---|---|
| Size and price | ||
| Share price | $1.44 | $1.46 |
| Change, 1 year | 33.3% | −67.0% |
| Beta (5Y) | 1.02 | 0.98 |
| Employees | 88 | 67 |
| StockData Score | ||
| Total score | 5 | 5 |
| Valuation score | 0 | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 4 (better) |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −21.6% (better) | −33.5% |
| Revenue growth, 5Y average | 32.2% | 66.2% (better) |
| Net income growth (TTM) | −192% | – |
| EPS growth (TTM) | −191% | – |
| Profitability | ||
| Gross margin | 7.2% (better) | −147% |
| Operating margin | −47.4% | 264% (better) |
| Net margin | −21.5% | 502% (better) |
| FCF margin | −44.2% (better) | −401% |
| Return on equity | −5.2% | 26.5% (better) |
| Return on invested capital | −19.2% | 10.7% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.51 (better) |
| Net debt / EBITDA | – | 2.34 |
| Interest coverage | – | 4.2× |
| Current ratio | 16.22 (better) | 1.20 |
| Piotroski F-score | 2 | 4 (better) |
| Ownership | ||
| Held by institutions | 0.09% | – |
| Held by insiders | 47.9% | 42.4% |
| Insider net buying, 12 months | – | −$85.1K |
Go deeper
- ICG stock overview
- ICG income statement
- ICG valuation and score
- NA stock overview
- NA income statement
- NA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.